Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma
Tài liệu tham khảo
Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, 64, 73, 10.1002/hep.28431
Piscaglia, 2016, Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study, Hepatology, 63, 827, 10.1002/hep.28368
Huang, 2021, Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention, Nat. Rev. Gastroenterol. Hepatol., 18, 223, 10.1038/s41575-020-00381-6
Riazi, 2022, The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis, Lancet. Gastroenterol. Hepatol., 7, 851, 10.1016/S2468-1253(22)00165-0
Yang, 2017, Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis, Clin. Gastroenterol. Hepatol., 15, 127, 10.1016/j.cgh.2016.07.034
Prieto, 2008, Inflammation, HCC and sex: IL-6 in the centre of the triangle, J. Hepatol., 48, 380, 10.1016/j.jhep.2007.11.007
Yang, 2014, Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis, Hepatology, 59, 1406, 10.1002/hep.26761
Palmisano, 2017, Role of Estrogens in the Regulation of Liver Lipid Metabolism, Adv. Exp. Med. Biol., 1043, 227, 10.1007/978-3-319-70178-3_12
Lonardo, 2019, Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps, Hepatology, 70, 1457, 10.1002/hep.30626
Ruggieri, 2010, Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity, Int. J. Cancer, 127, 499, 10.1002/ijc.25298
Della Torre, 2021, Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology, Cells, 10, 2502, 10.3390/cells10092502
DiStefano, 2020, NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment, Endocrinology, 161, 10.1210/endocr/bqaa134
Cai, 2017, High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance, Int. J. Obes., 41, 1341, 10.1038/ijo.2017.116
Zhang, 2013, Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat, J. Lipid Res., 54, 345, 10.1194/jlr.M028969
Dauki, 2020, Transcriptionally Active Androgen Receptor Splice Variants Promote Hepatocellular Carcinoma Progression, Cancer Res., 80, 561, 10.1158/0008-5472.CAN-19-1117
Camporez, 2013, Cellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet-induced hepatic and muscle insulin resistance, Endocrinology, 154, 1021, 10.1210/en.2012-1989
Dowman, 2010, Pathogenesis of non-alcoholic fatty liver disease, Qjm, 103, 71, 10.1093/qjmed/hcp158
Collins, 2019, In Vitro Models of the Liver: Disease Modeling, Drug Discovery and Clinical Applications
Zeilinger, 2016, Cell sources for in vitro human liver cell culture models, Exp. Biol. Med., 241, 1684, 10.1177/1535370216657448
Ramboer, 2015, Immortalized Human Hepatic Cell Lines for In Vitro Testing and Research Purposes, Methods Mol. Biol., 1250, 53, 10.1007/978-1-4939-2074-7_4
Nikolic, 2018, Models and On-Chip Systems: Biomaterial Interaction Studies With Tissues Generated Using Lung Epithelial and Liver Metabolic Cell Lines, Front. Bioeng. Biotechnol., 6, 120, 10.3389/fbioe.2018.00120
López-Terrada, 2009, Hep G2 is a hepatoblastoma-derived cell line, Hum. Pathol., 40, 1512, 10.1016/j.humpath.2009.07.003
Guengerich, 2019, Cytochrome P450 research and, J. Biol. Chem., 294, 1671, 10.1074/jbc.TM118.004144
Westerink, 2007, Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells, Toxicol. Vitro, 21, 1581, 10.1016/j.tiv.2007.05.014
Seo, 2019, Quantitative comparison of in vitro genotoxicity between metabolically competent HepaRG cells and HepG2 cells using the high-throughput high-content CometChip assay, Arch. Toxicol., 93, 1433, 10.1007/s00204-019-02406-9
Guo, 2021, 17β-Estradiol Promotes Apoptosis of HepG2 Cells Caused by Oxidative Stress by Increasing Foxo3a Phosphorylation, Front. Pharmacol., 12
Bai, 2017, Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis, Toxicol. Appl. Pharmacol., 324, 12, 10.1016/j.taap.2017.03.022
Donato, 2015, Culture and Functional Characterization of Human Hepatoma HepG2 Cells, Methods Mol. Biol., 1250, 77, 10.1007/978-1-4939-2074-7_5
Chavez-Tapia, 2012, Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease, BMC Gastroenterol., 12, 20, 10.1186/1471-230X-12-20
Gunn, 2020, Modifying nutritional substrates induces macrovesicular lipid droplet accumulation and metabolic alterations in a cellular model of hepatic steatosis, Physiol. Rep., 8, 10.14814/phy2.14482
Guillouzo, 2007, The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics, Chem. Biol. Interact., 168, 66, 10.1016/j.cbi.2006.12.003
Deng, 2019, Engineered Liver-on-a-Chip Platform to Mimic Liver Functions and Its Biomedical Applications: A Review, Micromachines, 10, 10.3390/mi10100676
Ryu, 2019, Targeting CYP4A attenuates hepatic steatosis in a novel multicellular organotypic liver model, J. Biol. Eng., 13, 69, 10.1186/s13036-019-0198-8
Doktorova, 2013, Transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models, Carcinogenesis, 34, 1393, 10.1093/carcin/bgt054
Bell, 2017, Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury, Drug Metab. Dispos., 45, 419, 10.1124/dmd.116.074369
Alkhatatbeh, 2016, Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG(2) cells: An in vitro model of non-alcoholic fatty liver disease, Exp. Ther. Med., 11, 1487, 10.3892/etm.2016.3069
Khalifa, 2022, Investigation of the Effect of Exendin-4 on Oleic Acid-Induced Steatosis in HepG2 Cells Using Fourier Transform Infrared Spectroscopy, Biomedicines, 10, 10.3390/biomedicines10102652
Cui, 2010, Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells, Am. J. Transl. Res., 2, 95
Wang, 2014, Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration, Br. J. Pharmacol., 171, 723, 10.1111/bph.12490
Swapna Sasi, 2020, Fructose-palmitate based high calorie induce steatosis in HepG2 cells via mitochondrial dysfunction: An in vitro approach, Toxicol. Vitro, 68, 10.1016/j.tiv.2020.104952
Justo, 2005, Gender dimorphism in rat liver mitochondrial oxidative metabolism and biogenesis, Am. J. Physiol. Cell Physiol., 289, C372, 10.1152/ajpcell.00035.2005
Stirone, 2005, Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels, Mol. Pharmacol., 68, 959, 10.1124/mol.105.014662
Galmés-Pascual, 2017, 17β-estradiol improves hepatic mitochondrial biogenesis and function through PGC1B, J. Endocrinol., 232, 297, 10.1530/JOE-16-0350
Farruggio, 2020, Genistein and 17β-Estradiol Protect Hepatocytes from Fatty Degeneration by Mechanisms Involving Mitochondria, Inflammasome and Kinases Activation, Cell. Physiol. Biochem., 54, 401, 10.33594/000000227
Gupta, 2021, Comparing in vitro human liver models to in vivo human liver using RNA-Seq, Arch. Toxicol., 95, 573, 10.1007/s00204-020-02937-6
Sharma, 2011, GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy, PLoS One, 6, 10.1371/journal.pone.0025269
Wobser, 2009, Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells, Cell Res., 19, 996, 10.1038/cr.2009.73
Baze, 2018, Three-Dimensional Spheroid Primary Human Hepatocytes in Monoculture and Coculture with Nonparenchymal Cells, Tissue Eng. Part C Methods, 24, 534, 10.1089/ten.tec.2018.0134
Seidemann, 2021, Influence of Genistein on Hepatic Lipid Metabolism in an In Vitro Model of Hepatic Steatosis, Molecules, 26, 10.3390/molecules26041156
Kozyra, 2018, Human hepatic 3D spheroids as a model for steatosis and insulin resistance, Sci. Rep., 8, 10.1038/s41598-018-32722-6
Kostrzewski, 2017, Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease, World J. Gastroenterol., 23, 204, 10.3748/wjg.v23.i2.204
Aoudjehane, 2020, Novel defatting strategies reduce lipid accumulation in primary human culture models of liver steatosis, Dis. Model. Mech., 13
Cai, 2006, Assessing self-renewal and differentiation in human embryonic stem cell lines, Stem Cell., 24, 516, 10.1634/stemcells.2005-0143
Trounson, 2006, The production and directed differentiation of human embryonic stem cells, Endocr. Rev., 27, 208, 10.1210/er.2005-0016
Steiner, 2010, Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension, Nat. Biotechnol., 28, 361, 10.1038/nbt.1616
Fernandez, 2013, Human induced pluripotent stem cells from basic research to potential clinical applications in cancer, BioMed Res. Int., 2013, 10.1155/2013/430290
Timilsina, 2022, Enhanced self-renewal of human pluripotent stem cells by simulated microgravity, NPJ Microgravity, 8, 22, 10.1038/s41526-022-00209-4
Lu, 2015, Morphological and Functional Characterization and Assessment of iPSC-Derived Hepatocytes for In Vitro Toxicity Testing, Toxicol. Sci., 147, 39, 10.1093/toxsci/kfv117
Szkolnicka, 2014, Deriving functional hepatocytes from pluripotent stem cells, Curr. Protoc. Stem Cell Biol., 30, 10.1002/9780470151808.sc01g05s30
Sinton, 2021, A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosis, iScience, 24, 10.1016/j.isci.2020.101931
Muñoz, 2022, Undifferentiated Induced Pluripotent Stem Cells as a Genetic Model for Nonalcoholic Fatty Liver Disease, Cell Mol Gastroenterol Hepatol, 14, 1174, 10.1016/j.jcmgh.2022.07.009
Graffmann, 2021, A stem cell based in vitro model of NAFLD enables the analysis of patient specific individual metabolic adaptations in response to a high fat diet and AdipoRon interference, Biol. Open, 10
Huang, 2015, Estradiol induces apoptosis via activation of miRNA-23a and p53: implication for gender difference in liver cancer development, Oncotarget, 6, 34941, 10.18632/oncotarget.5472
Katt, 2016, In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform, Front. Bioeng. Biotechnol., 4, 12, 10.3389/fbioe.2016.00012
Duval, 2017, Modeling Physiological Events in 2D vs. 3D Cell Culture, Physiology, 32, 266, 10.1152/physiol.00036.2016
Tirnitz-Parker, J.E.E. (2019). Hepatocellular Carcinoma. in. NBK549191.
Gillet, 2013, The clinical relevance of cancer cell lines, J. Natl. Cancer Inst., 105, 452, 10.1093/jnci/djt007
Xie, 2017, Long Noncoding RNA HCAL Facilitates the Growth and Metastasis of Hepatocellular Carcinoma by Acting as a ceRNA of LAPTM4B, Mol. Ther. Nucleic Acids, 9, 440, 10.1016/j.omtn.2017.10.018
Olsavsky Goyak, 2010, Hepatocyte differentiation, Methods Mol. Biol., 640, 115, 10.1007/978-1-60761-688-7_6
Qiu, 2016, Hepatocellular carcinoma cell lines retain the genomic and transcriptomic landscapes of primary human cancers, Sci. Rep., 6
Han, 2020, Androgen Receptor (AR)-TLR4 Crosstalk Mediates Gender Disparities in Hepatocellular Carcinoma Incidence and Progression, J. Cancer, 11, 1094, 10.7150/jca.30682
Teng, 2014, Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor, Mol. Cell. Endocrinol., 392, 23, 10.1016/j.mce.2014.05.007
Xu, 2012, Oestrogen attenuates tumour progression in hepatocellular carcinoma, J. Pathol., 228, 216, 10.1002/path.4009
Li, 2014, Over-expressed Testis-specific Protein Y-encoded 1 as a novel biomarker for male hepatocellular carcinoma, PLoS One, 9
Liu, 2017, Activation of SRY accounts for male-specific hepatocarcinogenesis: Implication in gender disparity of hepatocellular carcinoma, Cancer Lett., 410, 20, 10.1016/j.canlet.2017.09.013
Bigsby, 2011, The role for estrogen receptor-alpha and prolactin receptor in sex-dependent DEN-induced liver tumorigenesis, Carcinogenesis, 32, 1162, 10.1093/carcin/bgr094
Egan, 2009, Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish, Behav. Brain Res., 205, 38, 10.1016/j.bbr.2009.06.022
Yan, 2017, Tumor-Associated Neutrophils and Macrophages Promote Gender Disparity in Hepatocellular Carcinoma in Zebrafish, Cancer Res., 77, 1395, 10.1158/0008-5472.CAN-16-2200
Li, 2015, Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma, Int. J. Cancer, 136, 761, 10.1002/ijc.29052
Deng, 2015, Inhibition of MTA1 by ERα contributes to protection hepatocellular carcinoma from tumor proliferation and metastasis, J. Exp. Clin. Cancer Res., 34, 128, 10.1186/s13046-015-0248-0
Lin, 2013, Activation of estrogen receptors with E2 downregulates peroxisome proliferator-activated receptor γ in hepatocellular carcinoma, Oncol. Rep., 30, 3027, 10.3892/or.2013.2793
Hartwell, 2014, Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice, Proc. Natl. Acad. Sci. USA, 111, 11455, 10.1073/pnas.1404267111
Yang, 2012, Estrogen represses hepatocellular carcinoma (HCC) growth via inhibiting alternative activation of tumor-associated macrophages (TAMs), J. Biol. Chem., 287, 40140, 10.1074/jbc.M112.348763
Oh, 2021, Sex-dependent liver cancer xenograft models for predicting clinical data in the evaluation of anticancer drugs, Lab. Anim. Res., 37, 10, 10.1186/s42826-021-00087-z
Pok, 2016, Testosterone regulation of cyclin E kinase: A key factor in determining gender differences in hepatocarcinogenesis, J. Gastroenterol. Hepatol., 31, 1210, 10.1111/jgh.13232
Pez, 2019, In vitro transformation of primary human hepatocytes: Epigenetic changes and stemness properties, Exp. Cell Res., 384, 10.1016/j.yexcr.2019.111643
Bell, 2016, Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease, Sci. Rep., 6, 10.1038/srep25187
Ayed-Boussema, 2012, Effect of aflatoxin B1 on nuclear receptors PXR, CAR, and AhR and their target cytochromes P450 mRNA expression in primary cultures of human hepatocytes, Int. J. Toxicol., 31, 86, 10.1177/1091581811422453
Rieswijk, 2016, Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinoma, Toxicology, 350–352, 31, 10.1016/j.tox.2016.05.002
Wilkening, 2003, Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties, Drug Metab. Dispos., 31, 1035, 10.1124/dmd.31.8.1035
Vilas-Boas, 2019, Primary hepatocytes and their cultures for the testing of drug-induced liver injury, Adv. Pharmacol., 85, 1, 10.1016/bs.apha.2018.08.001
Grohmann, 2018, Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC, Cell, 175, 1289, 10.1016/j.cell.2018.09.053
Pok, 2013, Cyclin E facilitates dysplastic hepatocytes to bypass G1/S checkpoint in hepatocarcinogenesis, J. Gastroenterol. Hepatol., 28, 1545, 10.1111/jgh.12216
Teoh, 2010, Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis, Gastroenterology, 138, 1155, 10.1053/j.gastro.2009.11.008
Batmunkh, 2017, Estrogen Accelerates Cell Proliferation through Estrogen Receptor α during Rat Liver Regeneration after Partial Hepatectomy, Acta Histochem. Cytochem., 50, 39, 10.1267/ahc.17003
Kim, 2016, Estrogen-related receptor γ is upregulated in liver cancer and its inhibition suppresses liver cancer cell proliferation via induction of p21 and p27, Exp. Mol. Med., 48, e213, 10.1038/emm.2015.115
Parkinson, 2004, The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes, Toxicol. Appl. Pharmacol., 199, 193, 10.1016/j.taap.2004.01.010
Liu, 2010, Sex differences in subacute toxicity and hepatic microsomal metabolism of triptolide in rats, Toxicology, 271, 57, 10.1016/j.tox.2010.03.004
Aydin, 2010, Gender-dependent oxidative variations in liver of aged rats, Biogerontology, 11, 335, 10.1007/s10522-009-9257-8
Mennecozzi, 2015, Sex differences in liver toxicity-do female and male human primary hepatocytes react differently to toxicants in vitro?, PLoS One, 10, 10.1371/journal.pone.0122786
Ayed-Boussema, 2012, The mycotoxin, patulin, increases the expression of PXR and AhR and their target cytochrome P450s in primary cultured human hepatocytes, Drug Chem. Toxicol., 35, 241, 10.3109/01480545.2011.592194
Ayed-Boussema, 2012, Ochratoxin A induces CYP3A4, 2B6, 3A5, 2C9, 1A1, and CYP1A2 gene expression in primary cultured human hepatocytes: a possible activation of nuclear receptors, Drug Chem. Toxicol., 35, 71, 10.3109/01480545.2011.589438
Hay, 2008, Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling, Proc. Natl. Acad. Sci. USA, 105, 12301, 10.1073/pnas.0806522105
Sullivan, 2010, Generation of functional human hepatic endoderm from human induced pluripotent stem cells, Hepatology, 51, 329, 10.1002/hep.23335
Van Herck, 2017, Animal Models of Nonalcoholic Fatty Liver Disease-A Starter's Guide, Nutrients, 9, 10.3390/nu9101072
Friedman, 2018, Mechanisms of NAFLD development and therapeutic strategies, Nat. Med., 24, 908, 10.1038/s41591-018-0104-9
Cvitanović Tomaš, 2018, Computational Model: Sexual Aspects in Hepatic Metabolism and Abnormalities, Front. Physiol., 9, 360, 10.3389/fphys.2018.00360
McGregor, 2016, How to study the impact of sex and gender in medical research: a review of resources, Biol. Sex Differ., 7, 46, 10.1186/s13293-016-0099-1
Santhekadur, 2018, Preclinical models of non-alcoholic fatty liver disease, J. Hepatol., 68, 230, 10.1016/j.jhep.2017.10.031
Lombardi, 1968, Choline-deficiency fatty liver: impaired release of hepatic triglycerides, J. Lipid Res., 9, 437, 10.1016/S0022-2275(20)42721-X
Ghoshal, 1993, Choline deficiency, lipotrope deficiency and the development of liver disease including liver cancer: a new perspective, Lab. Invest., 68, 255
Koteish, 2002, Animal models of steatohepatitis, Best Pract. Res. Clin. Gastroenterol., 16, 679, 10.1053/bega.2002.0332
Kirsch, 2003, Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies, J. Gastroenterol. Hepatol., 18, 1272, 10.1046/j.1440-1746.2003.03198.x
Zeisel, 1990, Choline deficiency, J. Nutr. Biochem., 1, 332, 10.1016/0955-2863(90)90001-2
Tessitore, 1995, Sexually differentiated response to choline in choline deficiency and ethionine intoxication, Int. J. Exp. Pathol., 76, 125
Li, 2008, Phosphatidylcholine and choline homeostasis, J. Lipid Res., 49, 1187, 10.1194/jlr.R700019-JLR200
Michel, 2006, Choline transport for phospholipid synthesis, Exp. Biol. Med., 231, 490, 10.1177/153537020623100503
Resseguie, 2007, Phosphatidylethanolamine N-methyltransferase (PEMT) gene expression is induced by estrogen in human and mouse primary hepatocytes, FASEB J, 21, 2622, 10.1096/fj.07-8227com
Resseguie, 2011, Aberrant estrogen regulation of PEMT results in choline deficiency-associated liver dysfunction, J. Biol. Chem., 286, 1649, 10.1074/jbc.M110.106922
Guerrerio, 2012, Choline intake in a large cohort of patients with nonalcoholic fatty liver disease, Am. J. Clin. Nutr., 95, 892, 10.3945/ajcn.111.020156
Lee, 2016, Sex-specific metabolic interactions between liver and adipose tissue in MCD diet-induced non-alcoholic fatty liver disease, Oncotarget, 7, 46959, 10.18632/oncotarget.10506
Feldstein, 2010, Novel insights into the pathophysiology of nonalcoholic fatty liver disease, Semin. Liver Dis., 30, 391, 10.1055/s-0030-1267539
Fisher, 2012, FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis, Genes Dev., 26, 271, 10.1101/gad.177857.111
Kashireddy, 2004, Sex differences in choline-deficient diet-induced steatohepatitis in mice, Exp. Biol. Med., 229, 158, 10.1177/153537020422900204
Ito, 2007, Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high-fat diet, Hepatol. Res., 37, 50, 10.1111/j.1872-034X.2007.00008.x
Bachmann, 2022, Genetic background and sex control the outcome of high-fat diet feeding in mice, iScience, 25, 10.1016/j.isci.2022.104468
Kohli, 2010, High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis, Hepatology, 52, 934, 10.1002/hep.23797
Ganz, 2014, High fat diet feeding results in gender specific steatohepatitis and inflammasome activation, World J. Gastroenterol., 20, 8525, 10.3748/wjg.v20.i26.8525
Lusis, 2016, The Hybrid Mouse Diversity Panel: a resource for systems genetics analyses of metabolic and cardiovascular traits, J. Lipid Res., 57, 925, 10.1194/jlr.R066944
Norheim, 2017, Genetic and hormonal control of hepatic steatosis in female and male mice, J. Lipid Res., 58, 178, 10.1194/jlr.M071522
Chella Krishnan, 2018, Integration of Multi-omics Data from Mouse Diversity Panel Highlights Mitochondrial Dysfunction in Non-alcoholic Fatty Liver Disease, Cell Syst., 6, 103, 10.1016/j.cels.2017.12.006
Kurt, 2018, Tissue-specific pathways and networks underlying sexual dimorphism in non-alcoholic fatty liver disease, Biol. Sex Differ., 9, 46, 10.1186/s13293-018-0205-7
Chella Krishnan, 2021, Liver Pyruvate Kinase Promotes NAFLD/NASH in Both Mice and Humans in a Sex-Specific Manner, Cell. Mol. Gastroenterol. Hepatol., 11, 389, 10.1016/j.jcmgh.2020.09.004
Hui, 2015, The genetic architecture of NAFLD among inbred strains of mice, Elife, 4, 10.7554/eLife.05607
Fukai, 2011, Superoxide dismutases: role in redox signaling, vascular function, and diseases, Antioxid. Redox Signal., 15, 1583, 10.1089/ars.2011.3999
Krautbauer, 2013, Manganese superoxide dismutase is reduced in the liver of male but not female humans and rodents with non-alcoholic fatty liver disease, Exp. Mol. Pathol., 95, 330, 10.1016/j.yexmp.2013.10.003
Matsuzawa, 2007, Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet, Hepatology, 46, 1392, 10.1002/hep.21874
von Montfort, 2012, Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis, J. Hepatol., 57, 852, 10.1016/j.jhep.2012.05.024
Jena, 2017, Western Diet-Induced Dysbiosis in Farnesoid X Receptor Knockout Mice Causes Persistent Hepatic Inflammation after Antibiotic Treatment, Am. J. Pathol., 187, 1800, 10.1016/j.ajpath.2017.04.019
Yang, 2007, Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor, Cancer Res., 67, 863, 10.1158/0008-5472.CAN-06-1078
Hasegawa, 2020, Long-term effects of western diet consumption in male and female mice, Sci. Rep., 10, 10.1038/s41598-020-71592-9
Galipeau, 2002, Female rats are protected against fructose-induced changes in metabolism and blood pressure, Am. J. Physiol. Heart Circ. Physiol., 283, H2478, 10.1152/ajpheart.00243.2002
Kumagai, 1993, The effects of oestrogen and progesterone on insulin sensitivity in female rats, Acta Physiol. Scand., 149, 91, 10.1111/j.1748-1716.1993.tb09596.x
Vilà, 2011, Liver AMP/ATP ratio and fructokinase expression are related to gender differences in AMPK activity and glucose intolerance in rats ingesting liquid fructose, J. Nutr. Biochem., 22, 741, 10.1016/j.jnutbio.2010.06.005
Spruss, 2012, Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response, Mol. Med., 18, 1346, 10.2119/molmed.2012.00223
Gasparin, 2018, Sex differences in the development of hepatic steatosis in cafeteria diet-induced obesity in young mice, Biochim. Biophys. Acta, Mol. Basis Dis., 1864, 2495, 10.1016/j.bbadis.2018.04.004
Sampey, 2011, Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet, Obesity, 19, 1109, 10.1038/oby.2011.18
Johnson, 2016, Cafeteria diet-induced obesity causes oxidative damage in white adipose, Biochem. Biophys. Res. Commun., 473, 545, 10.1016/j.bbrc.2016.03.113
Diehl, 2005, Lessons from animal models of NASH, Hepatol. Res., 33, 138, 10.1016/j.hepres.2005.09.022
Nagarajan, 2012, Genetically modified mouse models for the study of nonalcoholic fatty liver disease, World J. Gastroenterol., 18, 1141, 10.3748/wjg.v18.i11.1141
Schiffrin, 2021, Sex Dimorphism of Nonalcoholic Fatty Liver Disease (NAFLD) in, Int. J. Mol. Sci., 22, 10.3390/ijms22189969
Rosen, 1999, PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro, Mol. Cell, 4, 611, 10.1016/S1097-2765(00)80211-7
Jacobs, 2019, Sex-Specific Differences in Fat Storage, Development of Non-Alcoholic Fatty Liver Disease and Brain Structure in Juvenile HFD-Induced Obese Ldlr-/-.Leiden Mice, Nutrients, 11, 10.3390/nu11081861
Dungubat, 2022, Age-dependent sex difference of non-alcoholic fatty liver disease in TSOD and db/db mice, PLoS One, 17, 10.1371/journal.pone.0278580
Nishida, 2013, Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndrome, Lab. Invest., 93, 230, 10.1038/labinvest.2012.155
Gathercole, 2022, AKR1D1 knockout mice develop a sex-dependent metabolic phenotype, J. Endocrinol., 253, 97, 10.1530/JOE-21-0280
Theiler-Schwetz, 2019, Bile acids and glucocorticoid metabolism in health and disease, Biochim. Biophys. Acta, Mol. Basis Dis., 1865, 243, 10.1016/j.bbadis.2018.08.001
Kolwankar, 2007, Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity, Clin. Gastroenterol. Hepatol., 5, 388, 10.1016/j.cgh.2006.12.021
de Wildt, 1999, Cytochrome P450 3A: ontogeny and drug disposition, Clin. Pharmacokinet., 37, 485, 10.2165/00003088-199937060-00004
Finn, 2009, Unsaturated fatty acid regulation of cytochrome P450 expression via a CAR-dependent pathway, Biochem. J., 417, 43, 10.1042/BJ20080740
Kumar, 2018, High fat diet induced obesity is mitigated in Cyp3a-null female mice, Chem. Biol. Interact., 289, 129, 10.1016/j.cbi.2018.05.001
Heintz, 2019, Cyp2b-null male mice are susceptible to diet-induced obesity and perturbations in lipid homeostasis, J. Nutr. Biochem., 70, 125, 10.1016/j.jnutbio.2019.05.004
Heintz, 2020, Gender differences in diet-induced steatotic disease in Cyp2b-null mice, PLoS One, 15, 10.1371/journal.pone.0229896
Dudakov, 2015, Interleukin-22: immunobiology and pathology, Annu. Rev. Immunol., 33, 747, 10.1146/annurev-immunol-032414-112123
Abdelnabi, 2022, Sex-Dependent Hepatoprotective Role of IL-22 Receptor Signaling in Non-Alcoholic Fatty Liver Disease-Related Fibrosis, Cell. Mol. Gastroenterol. Hepatol., 14, 1269, 10.1016/j.jcmgh.2022.08.001
Anezaki, 2009, Sex difference in the liver of hepatocyte-specific Pten-deficient mice: A model of nonalcoholic steatohepatitis, Hepatol. Res., 39, 609, 10.1111/j.1872-034X.2009.00494.x
Watahiki, 2020, Gender difference in development of steatohepatitis in p62/Sqstm1 and Nrf2 double-knockout mice, Exp. Anim., 69, 395, 10.1538/expanim.20-0028
Gao, 2007, Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals, Nat. Med., 13, 89, 10.1038/nm1525
Wu, 2016, Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma, Oncotarget, 7, 42762, 10.18632/oncotarget.8641
Fujii, 2013, A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma, Med. Mol. Morphol., 46, 141, 10.1007/s00795-013-0016-1
Hymel, 2022, Differential progression of unhealthy diet-induced hepatocellular carcinoma in obese and non-obese mice, PLoS One, 17, 10.1371/journal.pone.0272623
Soga, 1999, The FLS mouse: a new inbred strain with spontaneous fatty liver, Lab. Anim. Sci., 49, 269
Soga, 2003, Spontaneous development of hepatocellular carcinomas in the FLS mice with hereditary fatty liver, Cancer Lett., 196, 43, 10.1016/S0304-3835(03)00213-1
Asgharpour, 2016, A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer, J. Hepatol., 65, 579, 10.1016/j.jhep.2016.05.005
Mirshahi, 2022, Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma, Cell Rep., 38, 10.1016/j.celrep.2022.110454
Serra, 2020, Animal Models: A Useful Tool to Unveil Metabolic Changes in Hepatocellular Carcinoma, Cancers, 12, 10.3390/cancers12113318
Santos, 2017, Animal models as a tool in hepatocellular carcinoma research: A Review, Tumour Biol., 39, 10.1177/1010428317695923
Nagasue, 1992, Hepatocellular carcinoma and sex hormones, HPB Surg., 6, 1, 10.1155/1992/72761
Nakatani, 2001, Sex hormone dependency of diethylnitrosamine-induced liver tumors in mice and chemoprevention by leuprorelin, Jpn. J. Cancer Res., 92, 249, 10.1111/j.1349-7006.2001.tb01089.x
Xie, 2017, Sex-dependent effects on gut microbiota regulate hepatic carcinogenic outcomes, Sci. Rep., 7
Naugler, 2007, Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production, Science, 317, 121, 10.1126/science.1140485
Balkwill, 2001, Inflammation and cancer: back to Virchow?, Lancet, 357, 539, 10.1016/S0140-6736(00)04046-0
Simonetti, 1992, Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study, Ann. Intern. Med., 116, 97, 10.7326/0003-4819-116-2-97
Abiru, 2006, Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis, Liver Int., 26, 39, 10.1111/j.1478-3231.2005.01191.x
Soresi, 2006, Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma, World J. Gastroenterol., 12, 2563, 10.3748/wjg.v12.i16.2563
Sakurai, 2006, Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation, Proc. Natl. Acad. Sci. USA, 103, 10544, 10.1073/pnas.0603499103
Lee, 2004, Application of comparative functional genomics to identify best-fit mouse models to study human cancer, Nat. Genet., 36, 1306, 10.1038/ng1481
Wang, 2005, Gender-dependent hepatic alterations in H-ras12V transgenic mice, J. Hepatol., 43, 836, 10.1016/j.jhep.2005.04.012
Hunter, 1997, Oncoprotein networks, Cell, 88, 333, 10.1016/S0092-8674(00)81872-3
Santoni-Rugiu, 1996, Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha, Am. J. Pathol., 149, 407
Takagi, 1993, Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice, Cancer Res., 53, 4329
Callegari, 2012, Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model, Hepatology, 56, 1025, 10.1002/hep.25747
Wang, 2004, HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice, Hepatology, 39, 318, 10.1002/hep.20076
Moriya, 1998, The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice, Nat. Med., 4, 1065, 10.1038/2053
El-Serag, 2012, Epidemiology of viral hepatitis and hepatocellular carcinoma, Gastroenterology, 142, 1264, 10.1053/j.gastro.2011.12.061
Blencowe, 2022, Relative contributions of sex hormones, sex chromosomes, and gonads to sex differences in tissue gene regulation, Genome Res., 32, 807
Bakalov, 2009, X-chromosome gene dosage and the risk of diabetes in Turner syndrome, J. Clin. Endocrinol. Metab., 94, 3289, 10.1210/jc.2009-0384
Wiese, 2022, Chromosomal and gonadal sex drive sex differences in lipids and hepatic gene expression in response to hypercholesterolemia and statin treatment, Biol. Sex Differ., 13, 63, 10.1186/s13293-022-00474-8
Speliotes, 2010, PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease, Hepatology, 52, 904, 10.1002/hep.23768
Tsuei, 2011, Male germ cell-specific RNA binding protein RBMY: a new oncogene explaining male predominance in liver cancer, PLoS One, 6, 10.1371/journal.pone.0026948
Zeybel, 2015, Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease, Clin. Epigenetics, 7, 25, 10.1186/s13148-015-0056-6
Murphy, 2013, Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease, Gastroenterology, 145, 1076, 10.1053/j.gastro.2013.07.047
Vachher, 2022, Deciphering the role of aberrant DNA methylation in NAFLD and NASH, Heliyon, 8, 10.1016/j.heliyon.2022.e11119
García-Calzón, 2018, Sex Differences in the Methylome and Transcriptome of the Human Liver and Circulating HDL-Cholesterol Levels, J. Clin. Endocrinol. Metab., 103, 4395, 10.1210/jc.2018-00423
Zhou, 2019, Sex-associated preventive effects of low-dose aspirin on obesity and non-alcoholic fatty liver disease in mouse offspring with over-nutrition in utero, Lab. Invest., 99, 244, 10.1038/s41374-018-0144-2
Phan, 2021, The association of sex steroid hormone concentrations with non-alcoholic fatty liver disease and liver enzymes in US men, Liver Int., 41, 300, 10.1111/liv.14652
Fuller, 2021, Estradiol treatment or modest exercise improves hepatic health and mitochondrial outcomes in female mice following ovariectomy, Am. J. Physiol. Endocrinol. Metab., 320, E1020, 10.1152/ajpendo.00013.2021
Zhu, 2018, Hepatocyte estrogen receptor alpha mediates estrogen action to promote reverse cholesterol transport during Western-type diet feeding, Mol. Metab., 8, 106, 10.1016/j.molmet.2017.12.012
Shimizu, 1998, Suppressive effect of oestradiol on chemical hepatocarcinogenesis in rats, Gut, 42, 112, 10.1136/gut.42.1.112
Tsutsui, 1992, Promoting effect of ovariectomy on hepatocellular tumorigenesis induced in mice by 3'-methyl-4-dimethylaminoazobenzene, Virchows Arch. B Cell Pathol. Incl. Mol. Pathol., 62, 371, 10.1007/BF02899706
Li, 2012, Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer, Cell, 148, 72, 10.1016/j.cell.2011.11.026
Klein, 2016, Sex differences in immune responses, Nat. Rev. Immunol., 16, 626, 10.1038/nri.2016.90
Chen, 2021, Sex Differences in Macrophage Responses to Obesity-Mediated Changes Determine Migratory and Inflammatory Traits, J. Immunol., 206, 141, 10.4049/jimmunol.2000490
Klein, 2015, Sex-based differences in immune function and responses to vaccination, Trans. R. Soc. Trop. Med. Hyg., 109, 9, 10.1093/trstmh/tru167
Scotland, 2011, Sex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female mice, Blood, 118, 5918, 10.1182/blood-2011-03-340281
Straub, 2007, The complex role of estrogens in inflammation, Endocr. Rev., 28, 521, 10.1210/er.2007-0001
Fish, 2008, The X-files in immunity: sex-based differences predispose immune responses, Nat. Rev. Immunol., 8, 737, 10.1038/nri2394
Henstridge, 2019, Metabolic control and sex: A focus on inflammatory-linked mediators, Br. J. Pharmacol., 176, 4193, 10.1111/bph.14642
Spolarics, 2017, Inherent X-Linked Genetic Variability and Cellular Mosaicism Unique to Females Contribute to Sex-Related Differences in the Innate Immune Response, Front. Immunol., 8, 1455, 10.3389/fimmu.2017.01455
Carrel, 2005, X-inactivation profile reveals extensive variability in X-linked gene expression in females, Nature, 434, 400, 10.1038/nature03479
Ponziani, 2019, Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease, Hepatology, 69, 107, 10.1002/hep.30036
Grąt, 2016, Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis, Transplant. Proc., 48, 1687, 10.1016/j.transproceed.2016.01.077
Yeh, 2010, Gender disparity of hepatocellular carcinoma: the roles of sex hormones, Oncology, 78, 172, 10.1159/000315247